Valeant — spotting the dangers | Lex
Автор: Financial Times
Загружено: 2016-03-19
Просмотров: 1397
Описание:
Canadian drugmaker Valeant has lost billions off its market value after questions over its drug pricing and accounting. Rob Armstrong, head of Lex, reviews the warning signs for the pharmaceuticals group.
► Subscribe to the Financial Times on YouTube: http://bit.ly/FTimeSubs
For more video content from the Financial Times, visit http://www.FT.com/video
Twitter / ftvideo
Facebook / financialtimes
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке: